In the current study, we investigated the anti-Parkinson’s effect of azelaic acid (AA; 20 mg/kg, 40mg/kg, 80 mg/kg p.o.) against rotenone (2 mg/kg s.c.) induced Parkinson’s disease (PD) rat model. Rotenone was administered continuously for 35 days and caused behavioural alterations such as catalepsy, rigidity in muscles, posture instability and decrease in body weight, locomotor activity, and rearing behaviour.AAshowed significant (p<0.05) reversal in behavioural alterations induced by rotenone at 80 mg/kg dose on 28th and 35th day of treatment. Administration of azelaic acid along with levodopa-carbidopa (100mg/kg+25mg/kg p.o.) also showed significant reversal of behavioural alterations induced by rotenone and this effect was comparable to the effect of levodopa-carbidopa treatment group. The study proved the ameliorative effect of azelaic acidin rotenone induced PD rat model indicating its possible therapeutic potential for this devastating disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.